BioHealth Tech News and Events - 12/4/15
|
TOP STORY: PharmaCyte Biotech receive Orphan Drug designation
| PharmaCyte Biotech, a clinical stage biotech company, obtains Orphan Drug designation in Europe for its pancreatic cancer treatment using proprietary live-cell encapsulation technology. |
BioHealth Technology News
|
|
|
Gaithersburg's Emergent BioSolutions receives FDA approval to expand the label of BioThrax® (Anthrax Vaccine Adsorbed) to include post-exposure prophylaxis (PEP).
Baltimore's Profectus Biosciences demonstrates a single dose of multi-component vaccine provides complete protection against Zaire and Sudan species of Ebola and Marburg viruses.
Rockville's Synthetic Biologics announces positive topline results from first Phase 2a clinical trial of SYN-004, the company's candidate for prevention of C. difficile infection (CDI).
Germantown's Epigenomics AG novel panel of blood-based DNA methylation biomarkers shows promising results in the detection of lung cancer.
Rockville's Accelovance, a global CRO focusing in Oncology, Vaccines, and General Medicine expands its service offering through international strategic alliance.
Gaithersburg's Opgen receives contract funded by CDC to track occurrence of multidrug-resistant bacteria ("superbugs") in healthcare facilities throughout the District of Columbia.
Rockville's Therabron Therapeutics receives accelerated second tranche from Series B financing and expands investor syndicate to further the development of its drug candidate with potential to prevent chronic respiratory morbidities (CRM) in preterm infants.
Baltimore's PathSensors receives US Dept. of Defense contract for continuing supply of company's reagents and service for fast, accurate detection of potentially harmful pathogens.
Rockville's GenArraytion, Inc. announces MultiFLEX molecular assay optimization for the JPEO CBD in support of its Global Biosurveillance Technology Initiative (GBTI).
Baltimore's emocha Mobile Health receives NIH SBIR award to use its miDOT (mobile internet Directly Observed Therapy) medication adherence application to examine treatment of TB at four public health departments across Maryland.
Johns Hopkins pediatricians successfully treat a child with drug-resistant tuberculosis.
Rockville's Get Real Health selected to provide eHealth record service to Swedish citizens.
BioAssay Works, BioElectronics, EndoMaster, Endosurge, IOB Medical, Man and Machine, Moss, Inc., Opticul Diagnostics, Pevco, Reflexonic, and Tetracore all showcased their products in or near the MD Dept. of Commerce booth at MEDICA, the world's largest healthcare forum.
Baltimore's PathoVax, developer of proprietary HPV vaccine technology, wins "Best in Show" at Mid-Atlantic Bio Angels competition. Bel Air's Graftworx and Kera Biotech among the eight finalists for Startup Maryland's 2015 Pitch Across Maryland Competition.
Columbia's Digital Harmonic LLC combines Paul Reed Smith guitar maker's love of music, math and medicine with to improve clarity of X-ray technology.
Johns Hopkins researchers to use Apple Watch data to study epilepsy.
Partial reimbursement for internships is available to biohealth technology companies which offer internship positions to MD Tech Connect's prescreened applicants.
Governor Larry Hogan announces cuts in unemployment insurance taxes.
The MD Department of Commerce makes market research resources--Frost and Sullivan, Recap, Medtrack and BioMedTracker--available to Maryland-based biohealth entrepreneurs at its offices in Baltimore and Rockville. Please schedule appointments in advance.
|
Upcoming Deadlines and Events
|
Ahvana Health (Baltimore)
BioFactura (Frederick) To view more job opportunities, please check at the bottom
BioHealth Technology website. |
BioHealth Technology Innovator Spotlight
|
|
The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland, and also markets Maryland's many assets to companies across the nation and abroad.
The Department's Office of BioHealth Technology supports innovative start-ups and companies focused on animal and human health, health IT, research tools, and related technologies. These include those involving agricultural and marine bio, biodefense, therapeutics, vaccines, diagnostics, medical devices, biologics, nutraceuticals, personalized and regenerative medicine, digital health, mHealth, telemedicine, EHR, bioinformatics, health IT infrastructure, data center services, patient engagement, and wellness.
|
|
|
|
|